| |
IgM anti-PC, U/ml, baseline distribution
|
---|
n
|
Median
|
p value
|
---|
CV events during follow-up
|
Non-CV
|
512
|
64.19
|
0.020
|
CV
|
141
|
51.79
| |
Age, years
|
< 55
|
317
|
69.21
|
< 0.001
|
> 55
|
336
|
53.20
| |
Sex
|
Female
|
443
|
64.81
|
< 0.001
|
Male
|
210
|
52.90
| |
BMI, kg/m2
|
< 25
|
334
|
67.28
|
0.002
|
25–30
|
235
|
55.02
| |
> 30
|
84
|
47.56
| |
Smoking
|
Non-smoker
|
463
|
58.34
|
0.070
|
Current smoker
|
190
|
65.0
| |
Hypertension
|
Non-hypertensive
|
554
|
62.68
|
0.013
|
Hypertensive
|
99
|
47.91
| |
Diabetes mellitus
|
Non-diabetic
|
627
|
60.89
|
0.631
|
Diabetic
|
26
|
56.98
| |
Hyperlipidemia
|
Non-hyperlipidemic
|
648
|
60.88
|
0.658
|
Hyperlipidemic
|
5
|
48.17
| |
Seropositive
|
Seropositive
|
441
|
63.59
|
0.190
|
Seronegative
|
212
|
55.35
| |
DAS28 remission at 1 year
|
Remission
|
237
|
61.11
|
0.895
|
Non-remission
|
416
|
60.10
| |
DAS28 remission at 2 years
|
Remission
|
256
|
61.73
|
0.223
|
Non-remission
|
397
|
57.97
| |
- Statistical significance was tested with the Mann-Whitney U test
- BMI, body mass index; DAS28, Disease Activity Score 28-joint count; DAS28 remission, if DAS28 < 2.6; HAQ, Health Assessment Questionnaire; Anti-PC, phosphorylcholine antibodies